FindTrial
Sign In

Serum Progesterone And Retinopathy in Male Patients With Type 2 Diabetes: A Cross-Sectional Study

Serum Progesterone And Retinopathy in Male Patients With Type 2 Diabetes: A Cross-Sectional Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032408
Enrollment
Unknown
Registered
2020-04-27
Start date
2020-04-26
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

case series:Nil

Sponsors

Affiliated Hospital of Medical College Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Male patients with type 2 diabetes, aged between 18 and 80 years, were admitted to the Affiliated Hospital of Qingdao University.

Exclusion criteria

Exclusion criteria: 1. Patients with acute complications and severe infection of type 2 diabetes; 2. Patients with severe heart failure, severe liver disease and malignant tumor; 3. Those with low immune function; 5. Patients with previous history of severe osteoporosis and secondary fracture.

Design outcomes

Primary

MeasureTime frame
progesterone;—

Countries

China

Contacts

Public ContactWang Yangang

Affiliated Hospital of Medical College Qingdao University

wangyg1966@126.com+86 18661807293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026